vs
艾诺斯（ENS）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
艾诺斯的季度营收约是Royalty Pharma plc的1.5倍（$919.1M vs $622.0M），Royalty Pharma plc净利率更高（34.4% vs 9.8%，领先24.6%），Royalty Pharma plc同比增速更快（4.8% vs 1.4%），过去两年Royalty Pharma plc的营收复合增速更高（4.6% vs 0.5%）
艾诺斯是全球领先的工业储能系统及技术供应商，主营备用电源、动力电源类电池的生产，同时还提供电池充电器、电力设备、电池配件及户外设备防护机箱等相关产品，可充分满足各类工业场景的储能需求。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
ENS vs RPRX — 直观对比
营收规模更大
ENS
是对方的1.5倍
$622.0M
营收增速更快
RPRX
高出3.3%
1.4%
净利率更高
RPRX
高出24.6%
9.8%
两年增速更快
RPRX
近两年复合增速
0.5%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $919.1M | $622.0M |
| 净利润 | $90.4M | $214.2M |
| 毛利率 | 30.1% | — |
| 营业利润率 | 13.5% | 62.4% |
| 净利率 | 9.8% | 34.4% |
| 营收同比 | 1.4% | 4.8% |
| 净利润同比 | -21.3% | 2.9% |
| 每股收益（稀释后） | $2.40 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ENSRPRX
| Q4 25 | $919.1M | $622.0M | ||
| Q3 25 | $951.3M | $609.3M | ||
| Q2 25 | $893.0M | $578.7M | ||
| Q1 25 | $974.8M | $568.2M | ||
| Q4 24 | $906.2M | $593.6M | ||
| Q3 24 | $883.7M | $564.7M | ||
| Q2 24 | $852.9M | $537.3M | ||
| Q1 24 | $910.7M | $568.0M |
净利润ENSRPRX
| Q4 25 | $90.4M | $214.2M | ||
| Q3 25 | $68.4M | $288.2M | ||
| Q2 25 | $57.5M | $30.2M | ||
| Q1 25 | $96.5M | $238.3M | ||
| Q4 24 | $114.8M | $208.2M | ||
| Q3 24 | $82.3M | $544.0M | ||
| Q2 24 | $70.1M | $102.0M | ||
| Q1 24 | $60.9M | $4.8M |
毛利率ENSRPRX
| Q4 25 | 30.1% | — | ||
| Q3 25 | 29.1% | — | ||
| Q2 25 | 28.4% | — | ||
| Q1 25 | 31.2% | — | ||
| Q4 24 | 32.9% | — | ||
| Q3 24 | 28.5% | — | ||
| Q2 24 | 27.9% | — | ||
| Q1 24 | 27.9% | — |
营业利润率ENSRPRX
| Q4 25 | 13.5% | 62.4% | ||
| Q3 25 | 9.7% | 70.1% | ||
| Q2 25 | 9.7% | 36.3% | ||
| Q1 25 | 13.5% | 94.0% | ||
| Q4 24 | 15.7% | 60.9% | ||
| Q3 24 | 11.2% | — | ||
| Q2 24 | 10.7% | 50.2% | ||
| Q1 24 | 8.9% | -13.0% |
净利率ENSRPRX
| Q4 25 | 9.8% | 34.4% | ||
| Q3 25 | 7.2% | 47.3% | ||
| Q2 25 | 6.4% | 5.2% | ||
| Q1 25 | 9.9% | 41.9% | ||
| Q4 24 | 12.7% | 35.1% | ||
| Q3 24 | 9.3% | 96.3% | ||
| Q2 24 | 8.2% | 19.0% | ||
| Q1 24 | 6.7% | 0.8% |
每股收益（稀释后）ENSRPRX
| Q4 25 | $2.40 | $0.49 | ||
| Q3 25 | $1.80 | $0.67 | ||
| Q2 25 | $1.46 | $0.07 | ||
| Q1 25 | $2.39 | $0.55 | ||
| Q4 24 | $2.88 | $0.46 | ||
| Q3 24 | $2.01 | $1.21 | ||
| Q2 24 | $1.71 | $0.23 | ||
| Q1 24 | $1.48 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $450.1M | $618.7M |
| 总债务越低越好 | — | $9.0B |
| 股东权益账面价值 | $1.9B | $9.7B |
| 总资产 | $4.0B | $19.6B |
| 负债/权益比越低杠杆越低 | — | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资ENSRPRX
| Q4 25 | $450.1M | $618.7M | ||
| Q3 25 | $388.6M | $938.9M | ||
| Q2 25 | $346.7M | $631.9M | ||
| Q1 25 | $343.1M | $1.1B | ||
| Q4 24 | $463.2M | $929.0M | ||
| Q3 24 | $407.9M | $950.1M | ||
| Q2 24 | $344.1M | $1.8B | ||
| Q1 24 | $333.3M | $843.0M |
总债务ENSRPRX
| Q4 25 | — | $9.0B | ||
| Q3 25 | — | $8.9B | ||
| Q2 25 | — | $8.0B | ||
| Q1 25 | $1.1B | $7.6B | ||
| Q4 24 | — | $7.6B | ||
| Q3 24 | — | $7.6B | ||
| Q2 24 | — | $7.6B | ||
| Q1 24 | $802.0M | $6.1B |
股东权益ENSRPRX
| Q4 25 | $1.9B | $9.7B | ||
| Q3 25 | $1.9B | $9.6B | ||
| Q2 25 | $1.9B | $9.5B | ||
| Q1 25 | $1.9B | $9.8B | ||
| Q4 24 | $1.8B | $10.3B | ||
| Q3 24 | $1.8B | $10.3B | ||
| Q2 24 | $1.8B | $9.8B | ||
| Q1 24 | $1.8B | $9.9B |
总资产ENSRPRX
| Q4 25 | $4.0B | $19.6B | ||
| Q3 25 | $4.1B | $19.3B | ||
| Q2 25 | $4.1B | $18.3B | ||
| Q1 25 | $4.0B | $17.6B | ||
| Q4 24 | $4.0B | $18.2B | ||
| Q3 24 | $4.0B | $18.0B | ||
| Q2 24 | $3.6B | $17.7B | ||
| Q1 24 | $3.5B | $16.1B |
负债/权益比ENSRPRX
| Q4 25 | — | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | 0.57× | 0.78× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× | ||
| Q1 24 | 0.46× | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $184.6M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $171.3M | — |
| 自由现金流率自由现金流/营收 | 18.6% | — |
| 资本支出强度资本支出/营收 | 1.4% | — |
| 现金转化率经营现金流/净利润 | 2.04× | 3.86× |
| 过去12个月自由现金流最近4个季度 | $441.3M | — |
8季度趋势，按日历期对齐
经营现金流ENSRPRX
| Q4 25 | $184.6M | $827.1M | ||
| Q3 25 | $218.0M | $702.6M | ||
| Q2 25 | $968.0K | $364.0M | ||
| Q1 25 | $135.2M | $596.1M | ||
| Q4 24 | $81.1M | $742.5M | ||
| Q3 24 | $33.6M | $703.6M | ||
| Q2 24 | $10.4M | $658.2M | ||
| Q1 24 | — | $664.6M |
自由现金流ENSRPRX
| Q4 25 | $171.3M | — | ||
| Q3 25 | $197.1M | — | ||
| Q2 25 | $-32.1M | — | ||
| Q1 25 | $104.9M | — | ||
| Q4 24 | $56.8M | — | ||
| Q3 24 | $3.3M | — | ||
| Q2 24 | $-25.7M | — | ||
| Q1 24 | — | — |
自由现金流率ENSRPRX
| Q4 25 | 18.6% | — | ||
| Q3 25 | 20.7% | — | ||
| Q2 25 | -3.6% | — | ||
| Q1 25 | 10.8% | — | ||
| Q4 24 | 6.3% | — | ||
| Q3 24 | 0.4% | — | ||
| Q2 24 | -3.0% | — | ||
| Q1 24 | — | — |
资本支出强度ENSRPRX
| Q4 25 | 1.4% | — | ||
| Q3 25 | 2.2% | — | ||
| Q2 25 | 3.7% | — | ||
| Q1 25 | 3.1% | — | ||
| Q4 24 | 2.7% | — | ||
| Q3 24 | 3.4% | — | ||
| Q2 24 | 4.2% | — | ||
| Q1 24 | — | — |
现金转化率ENSRPRX
| Q4 25 | 2.04× | 3.86× | ||
| Q3 25 | 3.19× | 2.44× | ||
| Q2 25 | 0.02× | 12.06× | ||
| Q1 25 | 1.40× | 2.50× | ||
| Q4 24 | 0.71× | 3.57× | ||
| Q3 24 | 0.41× | 1.29× | ||
| Q2 24 | 0.15× | 6.45× | ||
| Q1 24 | — | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ENS
| Energy Systems | $399.5M | 43% |
| Motive Power | $352.0M | 38% |
| Services | $92.6M | 10% |
| Transferred Over Time | $38.2M | 4% |
| Other | $36.8M | 4% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
